BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In CML, the presence of the Philadelphia chromosome and its oncogenic product, the fusion oncoprotein BCR/ABL, is directly linked to multiple pathways involved in cell survival, growth promotion, and disease progression (203, 204).